These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 32585775
21. The effect of radical cystectomy on survival in patients with metastatic urothelial carcinoma of the urinary bladder. Luzzago S, Palumbo C, Rosiello G, Pecoraro A, Deuker M, Tian Z, Shariat SF, Saad F, de Cobelli O, Karakiewicz PI. J Surg Oncol; 2019 Dec; 120(7):1266-1275. PubMed ID: 31562831 [Abstract] [Full Text] [Related]
22. Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma. Porten S, Siefker-Radtke AO, Xiao L, Margulis V, Kamat AM, Wood CG, Jonasch E, Dinney CP, Matin SF. Cancer; 2014 Jun 15; 120(12):1794-9. PubMed ID: 24633966 [Abstract] [Full Text] [Related]
23. The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma. Cho YH, Hwang JE, Chung HS, Kim MS, Hwang EC, Jung SI, Kang TW, Kwon DD, Choi SH, Kim HT, Kim TH, Kwon TG, Noh JH, Kim MK, Kim CS, Kang SG, Kang SH, Cheon J, Lee CH, Ku JY, Ha HK, Tae BS, Jeong CW, Ku JH, Kwak C, Kim HH. Int Urol Nephrol; 2017 Aug 15; 49(8):1383-1390. PubMed ID: 28484945 [Abstract] [Full Text] [Related]
24. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy. Mazzone E, Nazzani S, Knipper S, Tian Z, Preisser F, Gallina A, Soulières D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI. Eur J Surg Oncol; 2019 Jul 15; 45(7):1253-1259. PubMed ID: 30755341 [Abstract] [Full Text] [Related]
25. Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity. Luo Y, Feng B, Wei D, Han Y, Li M, Zhao J, Lin Y, Hou Z, Jiang Y. Sci Rep; 2020 Oct 19; 10(1):17674. PubMed ID: 33077839 [Abstract] [Full Text] [Related]
26. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A. Inokuchi J, Kuroiwa K, Kakehi Y, Sugimoto M, Tanigawa T, Fujimoto H, Gotoh M, Masumori N, Ogawa O, Eto M, Ohyama C, Yamaguchi A, Matsuyama H, Ichikawa T, Asano T, Mizusawa J, Eba J, Naito S. World J Urol; 2017 Nov 19; 35(11):1737-1744. PubMed ID: 28508102 [Abstract] [Full Text] [Related]
27. Chemotherapy increases survival and downstaging of upper tract urothelial cancer. Davaro F, May A, McFerrin C, Raza SJ, Siddiqui S, Hamilton Z. Can J Urol; 2019 Oct 19; 26(5):9938-9944. PubMed ID: 31629443 [Abstract] [Full Text] [Related]
28. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy. Lee KS, Kim KH, Yoon YE, Choi KH, Yang SC, Han WK. Korean J Urol; 2015 Jan 19; 56(1):41-7. PubMed ID: 25598935 [Abstract] [Full Text] [Related]
29. The Efficacy of Postoperative Adjuvant Chemotherapy for Patients with pT3N0M0 Upper Tract Urothelial Carcinoma. Huang YC, Chen MF, Shi CS, Shindel AW, Huang CE, Pang ST, Chuang CK, Chen CS, Chang YH, Lin WY, Ho DR, Chin CC, Kuo YH, Wu CF. J Urol; 2015 Aug 19; 194(2):323-9. PubMed ID: 25796114 [Abstract] [Full Text] [Related]
30. Association between lymph node yield and survival among patients undergoing radical nephroureterectomy for urothelial carcinoma of the upper tract. Zareba P, Rosenzweig B, Winer AG, Coleman JA. Cancer; 2017 May 15; 123(10):1741-1750. PubMed ID: 28152158 [Abstract] [Full Text] [Related]
31. Oncological outcomes of radical nephroureterectomy for upper urinary tract urothelial neoplasia in Denmark. Azawi NH, Næraa SH, Subhi Y, Vásquez JL, Norus T, Dahl C, Thind P, Jensen JB. Scand J Urol; 2020 Feb 15; 54(1):58-64. PubMed ID: 31942812 [Abstract] [Full Text] [Related]
32. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. Isbarn H, Jeldres C, Shariat SF, Liberman D, Sun M, Lughezzani G, Widmer H, Arjane P, Pharand D, Fisch M, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. J Urol; 2009 Nov 15; 182(5):2177-81. PubMed ID: 19758662 [Abstract] [Full Text] [Related]
33. Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis. Necchi A, Mariani L, Lo Vullo S, Yu EY, Woods ME, Wong YN, Harshman LC, Alva A, Sternberg CN, Bamias A, Grivas P, Koshkin VS, Roghmann F, Dobruch J, Eigl BJ, Nappi L, Milowsky MI, Niegisch G, Pal SK, De Giorgi U, Recine F, Vaishampayan U, Berthold DD, Bowles DW, Baniel J, Theodore C, Ladoire S, Srinivas S, Agarwal N, Crabb S, Sridhar S, Golshayan AR, Ohlmann C, Xylinas E, Powles T, Rosenberg JE, Bellmunt J, van Rhijn B, Galsky MD, Hendricksen K, Young Academic Urologists-Urothelial Carcinoma Group-European Association of Urology and the Retrospective International Study of Invasive/Advanced Cancer of the Urothelium group. Eur Urol Focus; 2019 Mar 15; 5(2):242-249. PubMed ID: 28753897 [Abstract] [Full Text] [Related]
34. Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis. Danzig MR, Mallin K, McKiernan JM, Stadler WM, Sridhar SS, Morgan TM, Bochner BH, Lee CT. Cancer; 2018 Jun 15; 124(12):2507-2514. PubMed ID: 29624636 [Abstract] [Full Text] [Related]
35. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma. Zhang XK, Zhang ZL, Yang P, Cai MY, Hu WM, Yun JP, Zhou FJ, Qian CN, Cao Y. Jpn J Clin Oncol; 2015 Nov 15; 45(11):1069-75. PubMed ID: 26355163 [Abstract] [Full Text] [Related]
36. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study. Fujita K, Inamoto T, Yamamoto Y, Tanigawa G, Nakayama M, Mori N, Tsujihata M, Azuma H, Nonomura N, Uemura M. Int J Urol; 2015 Nov 15; 22(11):1006-12. PubMed ID: 26153093 [Abstract] [Full Text] [Related]
37. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer. Sato G, Yoshida T, Yanishi M, Saito R, Murota T, Kawa G, Kinoshita H, Matsuda T. Clin Genitourin Cancer; 2020 Apr 15; 18(2):e167-e173. PubMed ID: 31635939 [Abstract] [Full Text] [Related]
38. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma. Li X, Cui M, Gu X, Fang D, Li H, Qin S, Yang K, Zhu T, Li X, Zhou L, Gao XS, Wang D. World J Surg Oncol; 2020 May 30; 18(1):114. PubMed ID: 32473636 [Abstract] [Full Text] [Related]
39. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience. Cutress ML, Stewart GD, Tudor EC, Egong EA, Wells-Cole S, Phipps S, Thomas BG, Riddick AC, McNeill SA, Tolley DA. J Urol; 2013 Jun 30; 189(6):2054-60. PubMed ID: 23228378 [Abstract] [Full Text] [Related]
40. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study. Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y, Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka Y, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y. World J Urol; 2017 Oct 30; 35(10):1569-1575. PubMed ID: 28397000 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]